glp-1 diabetes news Study finds receptor agonists target fat over muscle for weight loss GLP-1-based therapies for diabetes, obesity

Retrieved from Grunvald, E., Shah, R., Hernaez, R., et al

Seeking medical attention is crucial to rehydrate your body and prevent complications

Reuters , Patients cut GLP-1 doses as coverage tightens (Aug 2025) ( [77] )

Others cover them for weight management only if the person meets clear clinical criteria, such as documented obesity and participation in a structured weight-management program

Under the CMMI demo, as Medicare reduces the prices it pays to Eli Lilly and Novo Nordisk for GLP-1s to treat diabetes, cardiovascular disease, and possible future indications, it can use the savings to pay for the expansion of coverage for GLP-1 drugs solely for weight loss